Nine month report January-September 2003

Nine month report January-September 2003 · Revenues up 8% currency adjusted · Operating earnings, EBITDA, up 11% currency adjusted · Earnings before tax, EBT, up 69% · Earnings per share increased to SEK 1.58 (0.66) · Strong operating cash flow at MSEK 1,312 (932) · Net debt reduced by SEK 1.8 billion since January 1, 2003 FOR FURTHER INFORMATION PLEASE CONTACT: Lars Granlöf, SVP, CFO, tel. +46-8-613 65 00, +46 70 513 65 48 Bengt Modéer, SVP, Corporate Communications, tel. +46 8 613 65 00, +46 70 513 65 33 Pia Irell, Director, Investor Relations, tel. +46 8 613 65 91, +46 70 513 65 91 Kevin Smith, President, Gambro Inc., Investor Relations U.S., tel. +1 303 231 4750 ------------------------------------------------------------ This information was brought to you by Waymaker http://www.waymaker.net The following files are available for download: http://www.waymaker.net/bitonline/2003/10/24/20031024BIT00050/wkr0001.doc The full report http://www.waymaker.net/bitonline/2003/10/24/20031024BIT00050/wkr0002.pdf The full report

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe